164 related articles for article (PubMed ID: 37400683)
21. Prolonged oral corticosteroid treatment in patients with systemic lupus erythematosus: An evaluation of 12-month economic and clinical burden.
Huang SP; DerSarkissian M; Gu YM; Duh MS; Wang MJ; Benson J; Vu J; Averell C; Bell CF
J Manag Care Spec Pharm; 2023 Apr; 29(4):365-377. PubMed ID: 36989451
[No Abstract] [Full Text] [Related]
22. Improved Health Outcomes in Patients with Systemic Lupus Erythematosus Following Early Belimumab Initiation Without Prior Immunosuppressant Use: A Real-World Descriptive Study.
Rubin B; Chen Y; Worley K; Rabideau B; Wu B; Chang R; DerSarkissian M
Rheumatol Ther; 2024 Jun; ():. PubMed ID: 38847995
[TBL] [Abstract][Full Text] [Related]
23. The Impact of Systemic Lupus Erythematosus Flares on Clinical and Economic Outcomes: The CHAMOMILE Claims Database Study in Germany.
Ding B; Pignot M; Garal-Pantaler E; Villinger B; Schefzyk S; Desta B; Stirnadel-Farrant HA; Schwarting A
Rheumatol Ther; 2024 Apr; 11(2):285-299. PubMed ID: 38252212
[TBL] [Abstract][Full Text] [Related]
24. Socioeconomic status at diagnosis influences the incremental direct medical costs of systemic lupus erythematosus: A longitudinal population-based study.
McCormick N; Marra CA; Sadatsafavi M; Aviña-Zubieta JA
Semin Arthritis Rheum; 2020 Feb; 50(1):77-83. PubMed ID: 31358362
[TBL] [Abstract][Full Text] [Related]
25. Cost-of-illness changes before and after the diagnosis of systemic lupus erythematosus: a nationwide, population-based observational study in Korea.
Kim H; Jang EJ; Cho SK; Han JY; Jeon Y; Jung SY; Sung YK
Rheumatology (Oxford); 2023 Dec; ():. PubMed ID: 38070482
[TBL] [Abstract][Full Text] [Related]
26. Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States.
Kariburyo F; Xie L; Sah J; Li N; Lofland JH
J Med Econ; 2020 Jan; 23(1):1-9. PubMed ID: 31589081
[No Abstract] [Full Text] [Related]
27. Total cost and cost predictors in systemic lupus erythematosus - 8-years follow-up of a Swedish inception cohort.
Jönsen A; Bengtsson AA; Hjalte F; Petersson IF; Willim M; Nived O
Lupus; 2015 Oct; 24(12):1248-56. PubMed ID: 25957301
[TBL] [Abstract][Full Text] [Related]
28. Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus.
Park SY; Joo YB; Shim J; Sung YK; Bae SC
Rheumatol Int; 2015 Nov; 35(11):1809-15. PubMed ID: 26254885
[TBL] [Abstract][Full Text] [Related]
29. An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins lupus cohort.
Watson P; Brennan A; Birch H; Fang H; Petri M
Rheumatology (Oxford); 2015 Apr; 54(4):623-32. PubMed ID: 25234659
[TBL] [Abstract][Full Text] [Related]
30. Systemic lupus erythematosus among male patients in Malaysia: how are we different from other geographical regions?
Shaharir SS; Kadir WDA; Nordin F; Bakar FA; Ting MWH; Jamil A; Mohd R; Wahab AA
Lupus; 2019 Jan; 28(1):137-144. PubMed ID: 30458692
[TBL] [Abstract][Full Text] [Related]
31. Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma.
Voorham J; Xu X; Price DB; Golam S; Davis J; Zhi Jie Ling J; Kerkhof M; Ow M; Tran TN
Allergy; 2019 Feb; 74(2):273-283. PubMed ID: 29987879
[TBL] [Abstract][Full Text] [Related]
32. The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States.
Clarke AE; Yazdany J; Kabadi SM; Durden E; Winer I; Griffing K; Costenbader KH
Semin Arthritis Rheum; 2020 Aug; 50(4):759-768. PubMed ID: 32531505
[TBL] [Abstract][Full Text] [Related]
33. A Retrospective Administrative Claims Database Evaluation of the Utilization of Belimumab in US Managed Care Settings.
Ke X; Eisenberg Lawrence DF; Oglesby A; Patel J; Kan H; Boggs R
Clin Ther; 2015 Dec; 37(12):2852-63. PubMed ID: 26547483
[TBL] [Abstract][Full Text] [Related]
34. Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study.
Tanaka Y; Mizukami A; Kobayashi A; Ito C; Matsuki T
Int J Rheum Dis; 2018 Aug; 21(8):1609-1618. PubMed ID: 30146745
[TBL] [Abstract][Full Text] [Related]
35. Healthcare costs associated with short-acting β
Attar-Zadeh D; Capstick T; Leese D; Arnetorp S; Rapsomaniki E; Da Costa KP; Maslova E; Xu Y; Gibson D; Quint JK
BJGP Open; 2023 Sep; 7(3):. PubMed ID: 36759020
[TBL] [Abstract][Full Text] [Related]
36. Healthcare resource utilization and costs 2 years pre- and post-lumbar spine surgery for stenosis: a national claims cohort study of 22,182 cases.
Koltsov JCB; Sambare TD; Alamin TF; Wood KB; Cheng I; Hu SS
Spine J; 2022 Jun; 22(6):965-974. PubMed ID: 35123048
[TBL] [Abstract][Full Text] [Related]
37. Demographics, treatment patterns, and healthcare utilization and cost of repository corticotropin injection in patients with systemic lupus erythematosus or rheumatoid arthritis.
Wu B; Deshpande G; Gu T; Popelar B; Philbin M; Wan GJ
J Med Econ; 2017 Nov; 20(11):1170-1177. PubMed ID: 28760047
[TBL] [Abstract][Full Text] [Related]
38. Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004-2015.
Hammond ER; Desta B; Near AM; Wang X; Jiang M
Lupus Sci Med; 2021 Sep; 8(1):. PubMed ID: 34556546
[TBL] [Abstract][Full Text] [Related]
39. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus.
Rivest C; Lew RA; Welsing PM; Sangha O; Wright EA; Roberts WN; Liang MH; Karlson EW
J Rheumatol; 2000 Mar; 27(3):680-4. PubMed ID: 10743808
[TBL] [Abstract][Full Text] [Related]
40. The economic burden of tuberous sclerosis complex in UK patients with renal manifestations: a retrospective cohort study in the clinical practice research datalink (CPRD).
Kingswood JC; Nasuti P; Patel K; Myland M; Siva V; Gray E
J Med Econ; 2016 Dec; 19(12):1116-1126. PubMed ID: 27310569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
